By Elena Vardon
Uniphar, a leading healthcare-services provider, announced on Wednesday that it anticipates meeting its earnings targets for 2023. The company reported in-line gross profit growth in the first half, setting a solid foundation for future success.
Although specific figures were not provided, analysts estimate that Uniphar will report earnings before interest, taxes, depreciation, and amortization of €116.5 million ($128.8 million) for the year, based on forecasts compiled by FactSet.
It is worth noting that rising interest rates may pose a minor challenge to the company’s earnings-per-share expectations. Despite this potential headwind, Uniphar remains optimistic about its performance.
During the six months ended June 30, Uniphar achieved organic gross profit growth of over 5%, demonstrating the company’s ability to generate sustainable revenue. Furthermore, the company’s normalized free cashflow conversion aligns with its mid-term guidance.
Chief Executive Ger Rabbette expressed his satisfaction with the company’s progress, stating, “Having achieved our strategic objective of doubling Ebitda within 5 years of IPO, we will unveil new medium-term targets along with our interim results.”